Stock Financial Ratios, Dividends, Split History

GGP / GGP, Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Market Cap ($M)19,580.58
Enterprise Value ($M)19,718.01
Book Value ($M)8,658.57
Book Value / Share9.03
Price / Book2.23
NCAV ($M)-14,277.08
NCAV / Share-14.90
Price / NCAV-1.39
Share Statistics
Weighted Average Number Diluted Shares Outstanding Adjustment 50,403,000
Common Shares Outstanding 957,017,459
Common Stock Shares Outstanding 956,982,536
Weighted Average Number Of Shares Outstanding Basic 897,156,000
Weighted Average Number Of Diluted Shares Outstanding 947,559,000
Preferred Stock Shares Outstanding 10,000,000
Scoring Models
Piotroski F-Score4.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Management Effectiveness (mra)
Return on Invested Capital (ROIC)0.08
Return on Assets (ROA)0.03
Return on Equity (ROE)0.08
Balance Sheet (mrq) ($M)
Quick Ration/a
Current Ration/a
Income Statement (mra) ($M)
Retail And Other Revenue0.00
Management And Other Fees Revenue From Unconsolidated Affiliates And Third Party Managed Properties0.00
Management And Other Fees Revenue105,144,000.00
Operating Income838.26
Net Income666.87
Earnings Per Share Basic0.72
Earnings Per Share Basic And Diluted0.00
Earnings Per Share Diluted0.68
Cash Flow Statement (mra) ($M)
Cash From Operations1,294.61
Cash from Investing-855.30
Cash from Financing-855.30
Identifiers and Descriptors
Central Index Key (CIK)1496048
Related CUSIPS

Split History

Stock splits are used by GGP, Inc. to keep share prices within reasonable numbers to encourage investment. If the share price of a security gets too high, a company can perform a stock split by issuing all shareholders an extra share, thereby halving the price of an individual share. If the share price gets too low, companies can do reverse splits. This is common when share prices drop below $1.00 and company's become in danger of being delisted. However, because of the cost, stock splits are not a normal business occurrence.

Coming soon

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

2018-06-22 - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

2018-06-22 - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

Related News Stories

Merger Arbitrage Mondays - June 18, 2018

2018-06-19 seekingalpha
Merger activity increased last week with two new deals announced and five pending deals closing. Several deals with large spreads on account of regulatory hurdles including Bayer's acquisition of Monsanto, AT&T's (NYSE:T) acquisition of Time Warner and China Oceanwide's acquisition of Genworth (NYSE:GNW) recently managed to get past those hurdles. (221-1)

A Macy's goes from mall mainstay to homeless shelter

2018-06-14 cnbc
ALEXANDRIA, Va. — Karleen Smith used to work at the Macy's in Landmark Mall, putting price tags on summer dresses, housewares and the latest styles of shoes. (8-0)

Why I Still Love Brookfield Property Partners

2018-06-13 seekingalpha
With market valuations rising substantially in the past year, it has been challenging to identify underperforming assets with attractive entry points. This is not the case with Brookfield Property Partners (NYSE:BPY). BPY remains one of the finest run commercial real estate organizations across the globe after reporting solid first quarter results marked by another y/y increase in cash flow and recycling of capital. (26-0)

SA Interview: Investing In REITs With Robert Ruggirello, CFA

2018-06-10 seekingalpha
Robert Ruggirello, CFA is the Managing Director of Brave Eagle Wealth Management, a NY-based Registered Investment Advisor. (19-0)

Retiring With Higher Yields

2018-06-07 seekingalpha
Whether you recently entered retirement or are planning to do so, you may be hunting for solid dividend stocks. (221-0)

CUSIP: 370023103